PT2959903T - Medicamento para tratar doença ocular - Google Patents

Medicamento para tratar doença ocular

Info

Publication number
PT2959903T
PT2959903T PT14754749T PT14754749T PT2959903T PT 2959903 T PT2959903 T PT 2959903T PT 14754749 T PT14754749 T PT 14754749T PT 14754749 T PT14754749 T PT 14754749T PT 2959903 T PT2959903 T PT 2959903T
Authority
PT
Portugal
Prior art keywords
medicine
eye disease
treating eye
treating
disease
Prior art date
Application number
PT14754749T
Other languages
English (en)
Inventor
Kakizuka Akira
Ikeda Hanako
Yoshimura Nagahisa
Muraoka Yuki
Original Assignee
Univ Kyoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto filed Critical Univ Kyoto
Publication of PT2959903T publication Critical patent/PT2959903T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT14754749T 2013-02-20 2014-02-19 Medicamento para tratar doença ocular PT2959903T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013031190 2013-02-20

Publications (1)

Publication Number Publication Date
PT2959903T true PT2959903T (pt) 2019-01-17

Family

ID=51391281

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14754749T PT2959903T (pt) 2013-02-20 2014-02-19 Medicamento para tratar doença ocular

Country Status (8)

Country Link
US (1) US9782420B2 (pt)
EP (1) EP2959903B1 (pt)
JP (1) JP6261011B2 (pt)
DK (1) DK2959903T3 (pt)
ES (1) ES2691805T3 (pt)
PL (1) PL2959903T3 (pt)
PT (1) PT2959903T (pt)
WO (1) WO2014129495A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3042658T (pt) 2013-09-04 2019-05-13 Univ Kyoto Composição medicinal que melhora a resistência à leptina
WO2017222042A1 (ja) * 2016-06-24 2017-12-28 国立大学法人京都大学 眼用医薬組成物
JP6308285B1 (ja) * 2016-12-08 2018-04-11 コニカミノルタ株式会社 透明基板積層体の製造方法および空中映像表示デバイスの製造方法
PL3733177T3 (pl) 2017-12-27 2022-11-14 Kyoto University Kompozycja do ochrony rogówki
CN112218635A (zh) * 2018-04-16 2021-01-12 国立大学法人京都大学 用于保护心肌细胞的药物组合物
JP7101982B2 (ja) 2018-07-31 2022-07-19 国立大学法人京都大学 脳梗塞の処置用の医薬組成物
WO2021079983A1 (ja) 2019-10-24 2021-04-29 国立大学法人京都大学 軟骨保護用の医薬組成物
JP2022170472A (ja) 2021-04-28 2022-11-10 国立大学法人京都大学 皮膚組織の異常を改善するための組成物
WO2024090512A1 (ja) * 2022-10-27 2024-05-02 株式会社京都創薬研究所 ナフタレン誘導体の結晶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679088B1 (en) 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
US20030065020A1 (en) 2001-07-13 2003-04-03 Catharine Gale Treatment of macular degeneration
US8457178B2 (en) 2007-03-26 2013-06-04 Qualcomm Incorporated Frequency offset estimator
WO2012014994A1 (ja) * 2010-07-30 2012-02-02 ダイトーケミックス株式会社 ナフタレン誘導体
WO2012043891A1 (ja) * 2010-09-30 2012-04-05 ダイトーケミックス株式会社 眼疾患処置薬

Also Published As

Publication number Publication date
JPWO2014129495A1 (ja) 2017-02-02
US9782420B2 (en) 2017-10-10
WO2014129495A1 (ja) 2014-08-28
US20160000810A1 (en) 2016-01-07
JP6261011B2 (ja) 2018-01-17
PL2959903T3 (pl) 2019-03-29
EP2959903A4 (en) 2016-08-03
EP2959903B1 (en) 2018-10-03
DK2959903T3 (en) 2019-01-21
ES2691805T3 (es) 2018-11-28
EP2959903A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
IL268987B (en) Glaucoma treatment system
IL278018A (en) Methods for the treatment or prevention of ophthalmological conditions
HK1222791A1 (zh) 用於眼睛的光線療法的裝置
IL243976B (en) kdm1a inhibitors for disease treatment
PL2764881T3 (pl) System leczenia medycznego
PL2959903T3 (pl) Lek do leczenia chorób oczu
HK1219653A1 (zh) 治療線粒體疾病的方法
HK1214526A1 (zh) 眼底疾病治療劑
HK1215164A1 (zh) 處理方法
IL246541A0 (en) From a versatile light-guided eyepiece treatment system
GB201314386D0 (en) Treatment system for aquaculture
GB201304872D0 (en) Treatment
EP2974730A4 (en) MEDICINES FOR RESPIRATORY DISEASES
SG11201601436YA (en) Ophthalmic solution
EP2968452A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF NETWORK DISEASES
EP3080602A4 (en) Treating neurodegenerative disease
EP2946777C0 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF NEUROPATHIC DISEASES
EP2870971A4 (en) MEDICAMENT FOR THE PREVENTION / TREATMENT OF AN OCULAR DISEASE
GB201313356D0 (en) Therapeutic Intervention
HK1223827A1 (zh) 用於治療眼疾病的 調節劑
EP2949329A4 (en) THERAPEUTIC AGAINST DEMYELINISING DISEASE
GB201307348D0 (en) Garment for therapeutic treatment
GB201307310D0 (en) Treatment
EP2979695A4 (en) THERAPEUTIC AGENT AGAINST EYE DISEASES
GB201321628D0 (en) Treatment of disease